4.7 Article

Z-DNA enhances immunotherapy by triggering death of inflammatory cancer-associated fibroblasts

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Mono a Mano: ZBP1's Love-Hate Relationship with the Kissing Virus

Alan Herbert et al.

Summary: Z-DNA binding protein (ZBP1) activates host defenses by initiating inflammatory cell death and regulated cell death, playing a crucial role in maintaining EBV latency and combating infectious threats.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis

Ting Zhang et al.

Summary: ADAR1 is a determinant of resistance to ICB therapy by repressing immunogenic dsRNA and Z-RNA. CBL0137 is a small molecule that activates ZBP1, reverses ICB unresponsiveness, and induced necroptosis.

NATURE (2022)

Article Multidisciplinary Sciences

ADAR1 mutation causes ZBP1-dependent immunopathology

Nicholas W. Hubbard et al.

Summary: The RNA-editing enzyme ADAR1 inhibits innate immune activation and pathology by disrupting the duplex structure of endogenous double-stranded RNA species. Alteration of the Z-DNA-binding domain (ZBD) of ADAR1 leads to activation of ZBP1, causing autoinflammatory pathology.

NATURE (2022)

Article Multidisciplinary Sciences

ADAR1 averts fatal type I interferon induction by ZBP1

Huipeng Jiao et al.

Summary: Mutations of the ADAR1 gene cause chronic activation of type I interferon responses, leading to severe diseases. The interaction between ADAR1 and another protein called ZBP1 prevents IFN activation. Deficiency or mutation of ZBP1's Z alpha domains reduces expression of IFN-stimulated genes and prevents early postnatal lethality in mice with mutated ADAR1 Z alpha domain.

NATURE (2022)

Article Multidisciplinary Sciences

ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation

Richard de Reuver et al.

Summary: The RNA-editing enzyme ADAR1 plays an important role in limiting the accumulation of immunostimulatory dsRNA. Reduced ADAR1 activity can lead to severe inflammatory diseases, while complete loss of ADAR1 activity is embryonically lethal and causes autoinflammation. ADAR1 not only prevents overactivation of MDA5 and PKR, but also inhibits the spontaneous activation of ZBP1.

NATURE (2022)

Article Multidisciplinary Sciences

ZBP1 promotes inflammatory responses downstream of TLR3/TLR4 via timely delivery of RIPK1 to TRIF

Hayley Muendlein et al.

Summary: ZBP1 is known for its role in cell death, but it also promotes inflammatory responses to bacterial lipopolysaccharide or double-stranded RNA. ZBP1 facilitates the delivery and ubiquitination of RIPK1, sustaining the activation of inflammatory signaling cascades. This finding highlights the crucial role of ZBP1 in regulating both bacterial and viral responses.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Oncology

Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer

Nina G. Steele et al.

Summary: The study reveals that Hedgehog signaling is uniquely activated in fibroblasts in PDAC, with varying levels of elevation in myofibroblastic CAFs compared to inflammatory CAFs. Inhibition of the Hedgehog pathway slows tumor growth, alters the composition of CAF subtypes, and impacts immune cell infiltration, leading to increased immunosuppression.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

RNA editing signatures identify melanoma patients who respond to Pembrolizumab or Nivolumab treatment

Jalal Siddiqui et al.

Summary: Studies have shown that RNA editing as a molecular marker for predicting response to immunotherapy has high accuracy and confidence, and can clearly distinguish melanoma patients who are sensitive to immunotherapy.

TRANSLATIONAL ONCOLOGY (2021)

Article Oncology

Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance

Reham Ajina et al.

Summary: The study found that T-cell antitumor immunity can induce a myeloid mimicry phenomenon in PDAC and activate immune resistance. Targeting the JAK/STAT signaling pathway improves the efficacy of anti-PD-1 therapy.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Rheumatology

JAK1: Number one in the family; number one in inflammation?

Francesca Romana Spinelli et al.

Summary: JAK1 is a key player in the signaling pathway of various cytokines, and selective JAK1 inhibitors are potential treatments for inflammatory diseases like rheumatoid arthritis and axial spondyloarthritis. While JAK1 is crucial for bone homeostasis and synovial inflammation, its role in new bone formation in axial spondyloarthritis needs further investigation.

RHEUMATOLOGY (2021)

Review Oncology

The Role of Cancer-Associated Fibroblasts in Tumor Progression

Rushikesh S. Joshi et al.

Summary: The review discusses the importance of cancer-associated fibroblasts (CAFs) in various cancer contexts as potential therapeutic targets. Identification of CAFs and understanding their role in promoting tumor progression may lead to the development of novel cancer therapies.

CANCERS (2021)

Article Immunology

High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells

Anette Teo Hansen Selno et al.

Summary: HMGB1, a non-histone protein, is released by stressed, dying, or dead cells into the extracellular matrix, potentially impacting cancer cells' ability to evade immune surveillance. Through recognition as a ligand, TLR4 mediates the induction of TGF-beta by HMGB1, leading to the expression of the immunosuppressive protein galectin-9 in cancer cells.

FRONTIERS IN IMMUNOLOGY (2021)

Review Virology

Benefits and Perils of Necroptosis in Influenza Virus Infection

Siddharth Balachandran et al.

JOURNAL OF VIROLOGY (2020)

Article Biochemistry & Molecular Biology

Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis

Ting Zhang et al.

Article Multidisciplinary Sciences

Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation

Huipeng Jiao et al.

NATURE (2020)

Review Cell Biology

The clearance of dead cells by efferocytosis

Emilio Boada-Romero et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Cell Biology

High Mobility Group Box 1 in Human Cancer

Bernardo L. Rapoport et al.

CELLS (2020)

Article Multidisciplinary Sciences

Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency

Parinaz Mehdipour et al.

NATURE (2020)

Article Oncology

Firing up the cold tumors by targeting Vps34

Bassam Janji et al.

ONCOIMMUNOLOGY (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Article Multidisciplinary Sciences

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

Fiona M. Behan et al.

NATURE (2019)

Article Immunology

ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1

Justin P. Ingram et al.

JOURNAL OF IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Jeffrey J. Ishizuka et al.

NATURE (2019)

Editorial Material Genetics & Heredity

A Genetic Instruction Code Based on DNA Conformation

Alan Herbert

TRENDS IN GENETICS (2019)

Review Oncology

CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer

Brooke A. Pereira et al.

TRENDS IN CANCER (2019)

Review Oncology

ADAR and Immune Silencing in Cancer

Alan Herbert

TRENDS IN CANCER (2019)

Review Biology

Z-DNA and Z-RNA in human disease

Alan Herbert

COMMUNICATIONS BIOLOGY (2019)

Review Biochemistry & Molecular Biology

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

Lorenzo Galluzzi et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Immunology

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

Daniel Ohlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Genetics & Heredity

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Zachary R. Chalmers et al.

GENOME MEDICINE (2017)

Article Microbiology

DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death

Roshan J. Thapa et al.

CELL HOST & MICROBE (2016)

Article Multidisciplinary Sciences

RIPK1 inhibits ZBP1-driven necroptosis during development

Kim Newton et al.

NATURE (2016)

Article Multidisciplinary Sciences

PGE2 induced in and released by dying cells functions as an inhibitory DAMP

Sho Hangai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Biochemistry & Molecular Biology

RIPK1-and RIPK3-induced cell death mode is determined by target availability

W. D. Cook et al.

CELL DEATH AND DIFFERENTIATION (2014)

Review Biochemistry & Molecular Biology

Crosstalk between TGF-β and hedgehog signaling in cancer

Delphine Javelaud et al.

FEBS LETTERS (2012)

Article Multidisciplinary Sciences

Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis

Andrew Oberst et al.

NATURE (2011)

Article Biochemistry & Molecular Biology

DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-κB

Manuele Rebsamen et al.

EMBO REPORTS (2009)